Abstract
Cancer is a disease of biological and cell cycle processes, driven by dosage of the limited set of drugs, resistance, mutations, and side effects. The identification of such limited set of drugs and their targets, pathways, and effects based on large scale multi-omics, multi-dimensional datasets is one of key challenging tasks in data-driven cancer genomics. This paper demonstrates the use of public databases associated with Drug-Target(Gene/Protein)-Disease to dissect the in-depth analysis of approved cancer drugs, their genetic associations, their pathways to establish a dosage balancing mechanism. This paper will also help to understand cancer as a disease associated pathways and effect of drug treatment on the cancer cells. We employ the Semantic Web approach to provide an integrated knowledge discovery process and the network of integrated datasets. The approach is employed to sustain the biological questions involving (1) Associated drugs and their omics signature, (2) Identification of gene association with integrated Drug-Target databases (3) Mutations, variants, and alterations from these targets (4) Their PPI Interactions and associated oncogenic pathways (5) Associated biological process aligned with these mutations and pathways to identify IC-50 level of each drug along-with adverse events and alternate indications. In principal this large semantically integrated database of around 30 databases will serve as Semantic Linked Association Prediction in drug discovery to explore and expand the dosage balancing and drug re-purposing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kumar, R., Chaudhary, K., Gupta, S., Singh, H., Kumar, S., Gautam, A., Kapoor, P., Raghava, G.P.: CancerDR: cancer drug resistance database. Scientific reports 3 (2013)
Gottlieb, A., Altman, R.B.: Integrating systems biology sources illuminates drug action. Clin. Pharmacol. Ther. 95(6), 663 (2014)
Hahn, W.C., Weinberg, R.A.: A Subway Map of Cancer Pathways. Nature Publishing Group (2002)
Spanheimer, P.M., Cyr, A.R., Gillum, M.P., Woodfield, G.W., Askeland, R.W., Weigel, R.J.: Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. Ann. Surg. 259(4), 793 (2014)
Croset, S., Drug repositioning and indication discovery using description logics (Doctoral dissertation, University of Cambridge) (2014)
Joshi-Tope, G., Gillespie, M., Vastrik, I., D’Eustachio, P., Schmidt, E., de Bono, B., Jassal, B., Gopinath, G.R., Wu, G.R., Matthews, L., Lewis, S.: Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 33(suppl 1), D428–D432 (2005)
Whirl-Carrillo, M., McDonagh, E.M., Hebert, J.M., Gong, L., Sangkuhl, K., Thorn, C.F., Altman, R.B., Klein, T.E.: Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92(4), 414 (2012)
Chen, X., Wang, Y., Wang, P., Lian, B., Li, C., Wang, J., Li, X., Jiang, W.: Systematic analysis of the associations between adverse drug reactions and pathways. In: BioMed Research International (2015)
Ritschel, W.A.: Handbook of Basic Pharmacokinetics (1976)
Patel, N., Itakura, T., Jeong, S., Liao, C.P., Roy-Burman, P., Zandi, E., Groshen, S., Pinski, J., Coetzee, G.A., Gross, M.E., Fini, M.E.: Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression. PloS one 10(2), e0117758 (2015)
Hassanzadeh, O., Kementsietsidis, A., Lim, L., Miller, R.J., Wang, M.: A linked data space for clinical trials. arXiv preprint arXiv:0908.0567
Pauwels, E., Stoven, V., Yamanishi, Y.: Predicting drug side-effect profiles: a chemical fragment-based approach. BMC Bioinformatics 12(1), 169 (2011)
Zheng, H., Wang, H., Xu, H., Wu, Y., Zhao, Z., Azuaje, F.: Linking biochemical pathways and networks to adverse drug reactions. IEEE Trans. NanoBiosci. 13(2), 131–137 (2014)
Ma, H., Zhao, H.: Drug target inference through pathway analysis of genomics data. Adv. Drug Delivery Rev. 65(7), 966–972 (2013)
Karp, P.D., Krummenacker, M., Paley, S., Wagg, J.: Integrated pathway-genome databases and their role in drug discovery. Trends Biotechnol. 17(7), 275–281 (1999)
Atias, N., Sharan, R.: An algorithmic framework for predicting side effects of drugs. J. Comput. Biol. 18(3), 207–218 (2011)
Zhou, H., Gao, M., Skolnick, J.: Comprehensive prediction of drug-protein interactions and side effects for the human proteome. Scientific reports, 5 (2015)
Pratanwanich, N., Lió, P.: Pathway-based Bayesian inference of drug-disease interactions. Mol. BioSyst. 10(6), 1538–1548 (2014)
Hardt, C., Beber, M.E., Rasche, A., Kamburov, A., Hebels, D.G., Kleinjans, J.C., Herwig, R.: pathway-level interpretation of drug-treatment data. Database, p. baw052 (2016)
Li, J., Lu, Z.: Pathway-based drug repositioning using causal inference. BMC Bioinformatics 14(16), 1 (2013)
Guney, E., Menche, J., Vidal, M. and Barábasi, A.L., Network-based in silico drug efficacy screening. Nature Commun. 7 (2016)
Mehdi, M., Iqbal, A., Hogan, A., Hasnain, A., Khan, Y., Decker, S., Sahay, R.: Discovering domain-specific public SPARQL endpoints: a life-sciences use-case. In: Proceedings of the 18th International Database Engineering & Applications Symposium, pp. 39–45. ACM, July 2014
Jha, A., Khan, Y., Iqbal, A., Zappa, A., Mehdi, M., Sahay, R., Rebholz-Schuhmann, D.: Linked Functional Annotation For Differentially Expressed Gene (DEG) Demonstrated using Illumina Body Map 2.0
Jha, A., Khare, A., Singh, R.: Features’ Compendium for Machine Learning in NGS Data Analysis (2015)
Pirró, G., Cuzzocrea, A.: RECAP: building relatedness explanations on the web. In: Proceedings of the 25th International Conference Companion on World Wide Web, pp. 235–238. International World Wide Web Conferences Steering Committee (2015)
Mehdi, M., Iqbal, A., Hasnain, A., Khan, Y., Decker, S., Sahay, R.: Utilizing domain-specific keywords for discovering public SPARQL endpoints: a life-sciences use-case. In: Proceedings of the 29th Annual ACM Symposium on Applied Computing, pp. 333–335. ACM, March 2014
Mehdi, M., Iqbal, A., Khan, Y., Decker, S., Sahay, R.: detecting inner-ear anatomical, clinical datasets in the Linked Open Data (LOD) cloud. In: Proceedings of International Workshop on Biomedical Data Mining, Modeling, Semantic Integration: A Promising Approach to Solving Unmet Medical Needs (BDM2I2015) (2015)
Callahan, A., Cruz-Toledo, J., Ansell, P., Dumontier, M.: Bio2RDF release 2: improved coverage, interoperability and provenance of life science linked data. In: Cimiano, P., Corcho, O., Presutti, V., Hollink, L., Rudolph, S. (eds.) ESWC 2013. LNCS, vol. 7882, pp. 200–212. Springer, Heidelberg (2013). doi:10.1007/978-3-642-38288-8_14
Acknowledgments
This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2289.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Jha, A., Mehdi, M., Khan, Y., Mehmood, Q., Rebholz-Schuhmann, D., Sahay, R. (2017). Drug Dosage Balancing Using Large Scale Multi-omics Datasets. In: Wang, F., Yao, L., Luo, G. (eds) Data Management and Analytics for Medicine and Healthcare. DMAH 2016. Lecture Notes in Computer Science(), vol 10186. Springer, Cham. https://doi.org/10.1007/978-3-319-57741-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-57741-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57740-1
Online ISBN: 978-3-319-57741-8
eBook Packages: Computer ScienceComputer Science (R0)